Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia

British Journal of Haematology

Volumn 119, Issue 3, 2002, Pages 803-809

  Zeng, Weihua ^a,c   Maciejewski, Jaroslaw P ^a   Chen, Guibin ^a   Risitano, Antonio M ^a   Kirby, Martha ^b   Kajigaya, Sachiko ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Building 10 ^*  (United States)

Author keywords

Aplastic anaemia; Autoimmune disease; CDR3 size; NKT cells; V 24J Q

Indexed keywords

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CELL ASSAY; CELL COUNT; CELL SIZE; CELL SPECIFICITY; CELL SUBPOPULATION; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; BLOTTING, SOUTHERN; BONE MARROW; CHILD; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYMPHOPENIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 0036433511     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03875.x     Document Type: Article

References (35)

1. Bendelac, A., Rivera, M.N., Park, S.H. & Roark, J.H. (1997) Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annual Review of Immunology, 15, 535-562.
2. Bix, M. & Locksley, R.M. (1995) Natural T cells. Cells that co-express NKRP-1 and TCR. Journal of Immunology, 155, 1020-1022.
3. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P. & Kronenberg, M. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. Journal of Experimental Medicine, 188, 1521-1528.
4. Camitta, B.M., Thomas, E.D., Nathan, D.G., Gale, R.P., Kopecky, K.J., Rappeport, J.M., Santos, G., Gordon-Smith, E.C. & Storb, R. (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood, 53, 504-514.
5. Davodeau, F., Peyrat, M.A., Necker, A., Dominici, R., Blanchard, F., Leget, C., Gaschet, J., Costa, P., Jacques, Y., Godard, A., Vie, H., Poggi, A., Romagne, F. & Bonneville, M. (1997) Close phenotypic and functional similarities between human and murine alpha-beta T cells expressing invariant TCR alpha-chains. Journal of Immunology, 158, 5603-5611.
6. Dellabona, P., Casorati, G., Friedli, B., Angman, L., Sallusto, F., Tunnacliffe, A., Roosneek, E. & Lanzavecchia, A. (1993) In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. Journal of Experimental Medicine, 177, 1763-1771.
7. Dellabona, P., Padovan, E., Casorati, G., Brockhaus, M. & Lanza-vecchia, A. (1994) An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. Journal of Experimental Medicine, 180, 1171-1176.
8. Godfrey, D.I., Hammond, K.J., Poulton, L.D., Smyth, M.J. & Baxter, A.G. (2000) NKT cells: Facts, functions and fallacies. Immunology Today, 21, 573-583.
9. Hamblin, T.J. (1996) Immunological abnormalities in myelodys-plastic syndromes. Seminars in Hematology, 33, 150-162.
10. Hong, S., Wilson, M.T., Serizawa, I., Wu, L., Singh, N., Naidenko, O.V., Miura, T., Haba, T., Scherer, D.C., Wei, J., Kronenberg, M., Koezuka, Y. & Van Kaer, L. (2001) The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Medicine, 7, 1052-1056.
11. Illes, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T. & Yamamura, T. (2000) Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Journal of Immunology, 164, 4375-4381.
12. Karadimitris, A., Gadola, S., Altamirano, M., Brown, D., Woolfson, A., Klenerman, P., Chen, J.L., Koezuka, Y., Roberts, I.A., Price, D.A., Dusheiko, G., Milstein, C., Fersht, A., Luzzatto, L. & Cerundolo, V. (2001) Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proceedings of the National Academy of Sciences of the United States of America, 98, 3294-3298.
13. Kaufman, D.W., Kelly, J.P., Jurgelon, J.M., Anderson, T., Issaragrisil, S., Wiholm, B.E., Young, N.S., Leaverton, P., Levy, M. & Shapiro, S. (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. European Journal of Haematology, 60, 23-30s.
14. Kojo, S., Adachi, Y., Keino, H., Taniguchi, M. & Sumida, T. (2001) Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis and Rheumatism, 44, 1127-1138.
15. Leite-de-Moraes, M.C. & Dy, M. (1997) Natural killer T cells: A potent cytokine-producing cell population. European Cytokine Network, 8, 229-237.
16. Miyamoto, K., Miyake, S. & Yamamura, T. (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature, 413, 531-534.
17. Nakao, S. (1997) Immune mechanism of aplastic anemia. International Journal of Hematology, 66, 127-134.
18. Nakao, S., Takami, A., Takamatsu, H., Zeng, W., Sugimori, N., Yamazaki, H., Miura, Y., Ueda, M., Shiobara, S., Yoshioka, T., Kaneshige, T., Yasukawa, M. & Matsuda, T. (1997) Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood, 19, 3691-3699
19. Pannetier, C., Even, J. & Kourilsky, P. (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunology Today, 16, 176-181.
20. Park, S.H. & Bendelac, A. (2000) CD1-restricted T-cell responses and microbial infection. Nature, 406, 788-792.
21. Porcelli, S., Yockey, C.E., Brenner, M.B. & Balk, S.P. (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. Journal of Experimental Medicine, 178, 1-16.
22. Rosenfeld, C. & List, A. (2000) A hypothesis for the pathogenesis of myelodysplastic syndromes: Implications for new therapies. Leukemia, 14, 2-8.
23. Sharif, S., Arreaza, G.A., Zucker, P., Mi, Q.S., Sondhi, J., Naidenko, O.V., Kronenberg, M., Koezuka, Y., Delovitch, T.L., Gombert, J.M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J.F. & Herbelin, A. (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nature Medicine, 7, 1057-1062.
24. Smyth, M.J. & Godfrey, D.I. (2000) NKT cells and tumor immunity: A double-edged sword. Nature Immunology, 1, 459-460.
25. Spada, F.M., Koezuka, Y. & Porcelli, S.A. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. Journal of Experimental Medicine, 188, 1529-1534.
26. Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K., Iwamoto, I. & Taniguchi, M. (1995) Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. Journal of Experimental Medicine, 182, 1163-1168.
27. Takahashi, T., Nieda, M., Koezuka, Y., Nicol, A., Porcelli, S.A., Ishikawa, Y., Tadokoro, K., Hirai, H. & Juji, T. (2000) Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glyco-sylceramide-pulsed monocyte-derived dendritic cells. Journal of Immunology, 164, 4458-4464.
28. Taniguchi, M. & Nakayama, T. (2000) Recognition and function of Valpha14 NKT cells. Seminars in Immunology, 12, 543-550.
29. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clinical Immunology, 100, 144-148.
30. Wilson, S.B., Kent, S.C., Patton, K.T., Orban, T., Jackson, R.A., Exley, M., Porcelli, S., Schatz, D.A., Atkinson, M.A., Balk, S.P., Strominger, J.L. & Hafler, D.A. (1998) Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature, 391, 177-181.
31. Young, N.S. (2000b) Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Seminars in Hematology, 37, 3-14.
32. Young, N.S. & Barrett, A.J. (2002) Immune modulation of myelodysplasia: Rationale and therapy. In: The Myelodysplastic Syndromes: Pathobiology and Clinical Management (ed. by J.M. Bennett), pp. 373-397, Marcel Dekker, New York.
33. Zeng, W., Nakao, S., Takamatsu, H., Yachie, A., Takami, A., Kondo, Y., Sugimori, N., Yamazaki, H., Miura, Y., Shiobara, S. & Matsuda, T. (1999a) Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: Evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia. Blood, 93, 3008-3016.
34. Zeng, D., Lewis, D., Dejbakhsh-Jones, S., Lan, F., Garcia-Ojeda, M., Sibley, R. & Strober, S. (1999b) Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. Journal of Experimental Medicine, 189, 1073-1081.
35. Zeng, W., Maciejewski, J.P., Chen, G. & Young, N.S. (2001) Limited heterogeneity of T cell receptor BV usage in aplastic anemia. Journal of Clinical Investigation, 108, 765-773.